Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis TC Chang, EA Wentzel, OA Kent, K Ramachandran, M Mullendore, ... Molecular cell 26 (5), 745-752, 2007 | 2476 | 2007 |
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes OA Kent, JT Mendell Oncogene 25 (46), 6188-6196, 2006 | 888 | 2006 |
Nuclear miRNA regulates the mitochondrial genome in the heart S Das, M Ferlito, OA Kent, K Fox-Talbot, R Wang, D Liu, N Raghavachari, ... Circulation research 110 (12), 1596-1603, 2012 | 398 | 2012 |
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice D Pramanik, NR Campbell, C Karikari, R Chivukula, OA Kent, JT Mendell, ... Molecular cancer therapeutics 10 (8), 1470-1480, 2011 | 376 | 2011 |
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway OA Kent, RR Chivukula, M Mullendore, EA Wentzel, G Feldmann, KH Lee, ... Genes & development 24 (24), 2754-2759, 2010 | 367 | 2010 |
Lessons from miR-143/145: the importance of cell-type localization of miRNAs OA Kent, MN McCall, TC Cornish, MK Halushka Nucleic acids research 42 (12), 7528-7538, 2014 | 216 | 2014 |
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets OA Kent, K Fox-Talbot, MK Halushka Oncogene 32 (20), 2576-2585, 2013 | 156 | 2013 |
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells OA Kent, ME Mullendore, EA Wentzel, P López-Romero, AC Tan, ... Cancer biology & therapy 8 (21), 2013-2024, 2009 | 148 | 2009 |
MicroRNA profiling of diverse endothelial cell types MN McCall, OA Kent, J Yu, K Fox-Talbot, AL Zaiman, MK Halushka BMC medical genomics 4, 1-13, 2011 | 133 | 2011 |
Role of pri-miRNA tertiary structure in miR-17~ 92 miRNA biogenesis SG Chaulk, GL Thede, OA Kent, Z Xu, E Gesner, RA Veldhoen, ... RNA biology 8 (6), 1105-1114, 2011 | 119 | 2011 |
Divergent effects of miR‐181 family members on myocardial function through protective cytosolic and detrimental mitochondrial microRNA targets S Das, M Kohr, B Dunkerly‐Eyring, DI Lee, D Bedja, OA Kent, AKL Leung, ... Journal of the American Heart Association 6 (3), e004694, 2017 | 106 | 2017 |
The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1 J Cullis, D Meiri, MJ Sandi, N Radulovich, OA Kent, M Medrano, ... Cancer cell 25 (2), 181-195, 2014 | 106 | 2014 |
Functional integration of microRNAs into oncogenic and tumor suppressor pathways CD Lotterman, OA Kent, JT Mendell Cell Cycle 7 (16), 2493-2499, 2008 | 100 | 2008 |
Crystal structure of a core spliceosomal protein interface MJ Schellenberg, RA Edwards, DB Ritchie, OA Kent, MM Golas, H Stark, ... Proceedings of the National Academy of Sciences 103 (5), 1266-1271, 2006 | 89 | 2006 |
Transcriptional regulation of miR-31 by oncogenic KRAS mediates metastatic phenotypes by repressing RASA1 OA Kent, JT Mendell, R Rottapel Molecular Cancer Research 14 (3), 267-277, 2016 | 86 | 2016 |
Identifying targets of miR-143 using a SILAC-based proteomic approach Y Yang, R Chaerkady, K Kandasamy, TC Huang, LDN Selvan, ... Molecular Biosystems 6 (10), 1873-1882, 2010 | 82 | 2010 |
Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2 Y Matsumoto, J La Rose, OA Kent, MJ Wagner, M Narimatsu, AD Levy, ... The Journal of clinical investigation 126 (12), 4482-4496, 2016 | 74 | 2016 |
Early organization of pre-mRNA during spliceosome assembly OA Kent, AM MacMillan nature structural biology 9 (8), 576-581, 2002 | 66 | 2002 |
Characterization of a U2AF-independent commitment complex (E′) in the mammalian spliceosome assembly pathway OA Kent, DB Ritchie, AM MacMillan Molecular and cellular biology 25 (1), 233-240, 2005 | 63 | 2005 |
Structuring of the 3′ splice site by U2AF65 OA Kent, A Reayi, L Foong, KA Chilibeck, AM MacMillan Journal of Biological Chemistry 278 (50), 50572-50577, 2003 | 54 | 2003 |